reference/30132051

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/30132051

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Clinical Trial, Phase I\|Clinical Trial, Phase II\|Journal Article\|Research Support, Non-U.S. Gov't\|Research Support, U.S. Gov't, P.H.S.
endingPage	620
issn	0360-3016
issueIdentifier	3
pageRange	614-620
publicationName	International journal of radiation oncology, biology, physics
startingPage	614
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_24809fa7b363ef2efc68e74eaae02ea0 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_09dfa92f79db1ca4d4643654b8f82b3f http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_c975659c912b1d802402cca8e0016b17 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_6d8b970399d48f8c94a22a7dfa61970d
bibliographicCitation	Valicenti RK, Winter K, Cox JD, Sandler HM, Bosch W, Vijayakumar S, Michalski J, Purdy J. RTOG 94-06: Is the addition of neoadjuvant hormonal therapy to dose-escalated 3D conformal radiation therapy for prostate cancer associated with treatment toxicity? International Journal of Radiation OncologyBiologyPhysics. 2003 Nov;57(3):614–20. doi: 10.1016/s0360-3016(03)00640-0.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_06d19d1a1753c670d7d588a7b481f000 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_728a7dc28736a8efb7894c5aff79d911 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b66b397e6d7c91f1cb5da2d3e60769a6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_eb66a843d5c008a7c3db1b9cd86f6c3e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_418f4156d0d7276b628e50ac19ea58eb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f3e73d4d93465c804c2305261fd8ce59 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0e6c8b7aa18c8577927e9a8e58d8aca0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dccf52bb267ef9cd5917c937319a40cb
date	2003-11-01^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1016/s0360-3016%2803%2900640-0 https://pubmed.ncbi.nlm.nih.gov/14529764
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4036 https://portal.issn.org/resource/ISSN/0360-3016
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	RTOG 94-06: Is the addition of neoadjuvant hormonal therapy to dose-escalated 3D conformal radiation therapy for prostate cancer associated with treatment toxicity?
discusses	http://id.nlm.nih.gov/mesh/M0010538 http://id.nlm.nih.gov/mesh/M0026444
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D006728Q000627 http://id.nlm.nih.gov/mesh/D011880Q000379 http://id.nlm.nih.gov/mesh/D020266Q000009 http://id.nlm.nih.gov/mesh/D011471Q000188 http://id.nlm.nih.gov/mesh/D011471Q000532
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D011471Q000097 http://id.nlm.nih.gov/mesh/D005500 http://id.nlm.nih.gov/mesh/D020360 http://id.nlm.nih.gov/mesh/D011832Q000517 http://id.nlm.nih.gov/mesh/D020714 http://id.nlm.nih.gov/mesh/D011879 http://id.nlm.nih.gov/mesh/D000230 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D017430Q000097 http://id.nlm.nih.gov/mesh/D015999 http://id.nlm.nih.gov/mesh/D003131
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8983 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5995 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5755

Showing number of triples: 1 to 55 of 55.